retatrutide regulatory approval approval: FDA status, clinical trial results, and when it could be available ⚠️ BEWARE OF RETATRUTIDE SOLD

Hydration requirements increase during treatment

[1] [2] 1 mg per week The lowest tested dose, primarily intended to evaluate tolerability and establish baseline safety

Roche indicated that patients seeking maximum weight loss might choose more potent therapies like its experimental dual-acting enicepatide, while others might prefer more modest weight loss with fewer side effects for easier long-term adherence

Loss of muscle mass When people lose weight through dieting, medication, or bariatric surgery, about one-third of the weight lost is lean mass, Almandoz explained

Success rates depend on age, egg and sperm quality, uterine health, and clinic experience